Compounds of the formula I: including a stereoisomer thereof, or an N-oxide, a pharmaceutically acceptable addition salt, or a pharmaceutically acceptable addition solvate thereof； useful as HCV inhibitors； processes for preparing these compounds as well as pharmaceutical compositions comprising these compounds as active ingredient.
